Cross-Sector entity

Rosen Law Firm

Company
5

Rosen Law Firm is most often covered alongside Enphase Energy, Inc., which appears in 5 of these 16 stories. That works out to roughly 3.6 stories per week across a 31-day span. The busiest single day carried 3. The clearest coverage concentration is regulation: 8 of 16 stories, with the rest divided among 4 other categories.

16 verified stories tracked

Last mentioned: Mar 21, 2026

Entity pulse

Recent coverage · Rosen Law Firm

16 stories
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Rosen Law Firm

Rosen Law Firm is most often covered alongside Enphase Energy, Inc., which appears in 5 of these 16 stories. That works out to roughly 3.6 stories per week across a 31-day span. The busiest single day carried 3. The clearest coverage concentration is regulation: 8 of 16 stories, with the rest divided among 4 other categories. Each carries 3.8 original sources on average. Negative sentiment appears in 0% of the tracked stories. This profile follows 16 Cross-Sector stories mentioning Rosen Law Firm across the period from February 19, 2026 to March 21, 2026.

Stories tracked
16
Per week
3.6
Negative
0%
Sources per story
3.8

Computed from the 16 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Rosen Law Firm. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Potential Settlement

    Typical timeframe for securities class actions to reach settlement or dismissal phases.

  2. Formal Complaint Filing

    Anticipated filing of detailed class action complaints if investigations yield actionable evidence.

  3. Lead Plaintiff Deadline

    Expected 60-day window for investors to move the court to serve as lead plaintiff.

  4. Lead Plaintiff Deadline

    The final date for investors to petition the court to lead the litigation against Enphase.

  5. ENPH Deadline

    Final day for Enphase Energy investors to move for lead plaintiff status.

  6. PMI Deadline

    Final day for Picard Medical investors to move for lead plaintiff status.

  7. PSFE Deadline

    Final day for Paysafe investors to move for lead plaintiff status.

  8. Follow-up Counsel Alert

    Rosen Law Firm issues a second alert emphasizing its role as recognized counsel.

  9. Investigation Announced

    Rosen Law Firm officially launches investigation into potential securities fraud at SMCI.

  10. Rosen Law Firm Alert

    First major solicitation for Barclays investors to join class action litigation.

  11. Investigation Launch

    Rosen Law Firm issues public notices regarding probes into Barclays and Vital Farms.

  12. SEC Filing Activity

    Barclays submits multiple regulatory filings to the SEC.

  13. Institutional Sell-off

    Victory Capital Management Inc. reduces its holdings in Super Micro Computer shares.

  14. Litigation Expansion

    Additional filings and reminders are issued to shareholders by Pomerantz.

  15. Pomerantz Commencement

    Pomerantz LLP officially files class action litigation against the company.

  16. Legal Notices Issued

    Faruqi & Faruqi, LLP issues formal reminders for class action deadlines.

  17. Paysafe Earnings

    Paysafe reports mixed Q4 2025 results and issues FY26 outlook.

  18. Institutional Investment

    Integrated Financial Solutions Inc. makes a new $3.31 million investment in SMCI.

  19. Legal Counsel Announcement

    Rosen Law Firm publicly encourages investors to secure counsel before the upcoming deadline.

  20. Rosen Law Firm Notice

    Rosen Law Firm encourages investors to secure counsel before the April deadline.

Stories mentioning Rosen Law Firm 16

Finance regulation Neutral 5

Rosen Law Firm Targets Barclays and Vital Farms in Dual Securities Probes

Rosen Law Firm has initiated separate investigations into Barclays PLC and Vital Farms, Inc. for potential violations of federal securities laws. These probes signal a heightened period of litigation risk for both the global banking giant and the ethical food producer as the firm seeks lead plaintiffs for potential class action suits.

2 sources
Climate regulation Neutral 5

Pomerantz LLP Files Class Action Against Enphase Energy Over Alleged Fraud

Pomerantz LLP has initiated a class action lawsuit against Enphase Energy, Inc. (ENPH), alleging securities fraud and misleading statements. The litigation focuses on potential violations of federal securities laws that may have impacted the company's stock value and investor confidence.

2 sources
Finance regulation Neutral 5

Securities Class Action Deadlines Loom for Paysafe, Enphase, and Picard Medical

Faruqi & Faruqi, LLP has issued critical reminders for investors in Paysafe, Picard Medical, and Enphase Energy regarding upcoming lead plaintiff deadlines in April 2026. These legal actions follow periods of financial reporting and market volatility, signaling a tightening of regulatory and investor oversight for these entities.

3 sources
Finance regulation Neutral 5

Enphase Energy Faces Securities Class Action Over Alleged Misleading Disclosures

Enphase Energy, Inc. is facing a significant securities class action lawsuit alleging that the company issued materially false or misleading statements during a critical growth period in 2025. The Rosen Law Firm has set an April 20, 2026, deadline for investors who suffered losses between April and October 2025 to seek lead plaintiff status.

2 sources
Finance regulation Neutral 5

Corcept Therapeutics Faces Securities Fraud Suit Following Class Period Volatility

Corcept Therapeutics (NASDAQ: CORT) is the target of a class action lawsuit alleging securities fraud during a critical 14-month period of operational and legal shifts. The Rosen Law Firm is seeking lead plaintiffs for a class period that concluded in late 2025, amid intensifying pressure on the company's core product patents.

10 sources
Biotech pharma Neutral 5

Corcept Therapeutics Faces Securities Fraud Lawsuit Amid Korlym Patent Battle

Rosen Law Firm has filed a class action lawsuit against Corcept Therapeutics (NASDAQ: CORT), alleging securities fraud during a period of intense patent litigation over its flagship drug, Korlym. The lawsuit covers investors who purchased shares between October 2024 and December 2025, following significant volatility linked to generic competition threats.

10 sources
Legal corporate law Neutral 5

Corcept Therapeutics Faces Securities Fraud Suit Over Disclosure Failures

Corcept Therapeutics (NASDAQ: CORT) is the target of a class action lawsuit alleging securities fraud between October 2024 and December 2025. The Rosen Law Firm is leading the litigation, which centers on claims that the company misled investors regarding its business operations and regulatory compliance. This legal challenge marks a critical period of scrutiny for the pharmaceutical firm's corporate governance and public disclosure practices.

10 sources

Source: Finger Lakes Times · Pr Newswire

Finance markets Neutral 5

Rosen Law Firm Targets PayPal in Class Action Following SEC Disclosures

The Rosen Law Firm has initiated a class action investigation into PayPal Holdings, Inc. (PYPL), urging investors to secure legal counsel following recent financial disclosures. The move comes after a series of SEC filings in early February 2026 revealed significant shifts in operations and executive leadership.

3 sources
Legal corporate law Neutral 5

Rosen Law Firm Targets PayPal in Securities Class Action Over Growth Disclosures

The Rosen Law Firm has initiated a securities class action investigation against PayPal Holdings, Inc., following a significant stock drop linked to the company's February 2026 financial disclosures. The firm is urging affected investors to secure legal counsel before the upcoming lead plaintiff deadline to address allegations of materially false or misleading business statements.

3 sources

Source: Postregister · Bluefield Daily Telegraph